Copyright © 2025 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

@article{160472,
        author = {Vyas G V and Pallavi Garkhede and Rawat S S and Jaybhaye S S and Hatkar A D and Phoke S V and Manisha Garkhede},
        title = {AN OVERVIEW OF CONTRACT RESEARCH ORGANISATION},
        journal = {International Journal of Innovative Research in Technology},
        year = {},
        volume = {10},
        number = {1},
        pages = {675-679},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=160472},
        abstract = {Sometimes also called contract house, clinical research organisation (overall term: trial manon agement organisation), third party service; EC (III): “scientific body (commercial or academic) to which a sponsor may transfer responsibility for some of its tasks or obligations”; FDA: “If a sponsor has transferred any obligations for the conduct of any clinical study to a CRO, a statement containing the name and address of the CRO, identification of the clinical study, and a listing of the obligations transferred may be submitted” (with a new drug application},
        keywords = {Control release form, Scientific Body, Party service,clinical research organization },
        month = {},
        }